S100A9 and Sepsis: In contrast, pharmacological inhibition of AMPK with Compound C dramatically abolished the S100A9 KO-mediated amelioration of liver dysfunction and injury and mitochondrial dysfunction after sepsis in vivo (Figure 5), suggesting that AMPK-mediated mitochondrial energy metabolism is essential for the attenuation of sepsis-induced liver injury.